Related Experiment Videos
Genetic screening for hereditary diffuse gastric cancer
Carlo Oliveira1, Raquel Seruca, Carlos Caldas
1Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Portugal. carlaol@ipatimup.pt
Expert Review of Molecular Diagnostics
|March 22, 2003
Summary
Hereditary diffuse gastric cancer is linked to E-cadherin gene mutations. This review covers gastric cancer genetics, E-cadherin, and potential candidate genes for improved genetic counseling and early intervention.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Hereditary diffuse gastric cancer (HDGC) is a significant clinical concern.
- Recent advances have elucidated the genetic underpinnings of HDGC.
Purpose of the Study:
- To review the epidemiology, pathology, and genetics of gastric cancer.
- To discuss E-cadherin mutations and candidate genes in HDGC.
- To highlight the importance of genetic counseling and presymptomatic intervention.
Main Methods:
- Literature review focusing on hereditary diffuse gastric cancer.
- Analysis of genetic mutations, particularly in the E-cadherin gene.
- Identification and discussion of potential alternative candidate genes.
Main Results:
- Germline mutations in the E-cadherin gene are a primary cause of HDGC.
- HDGC families exhibit a high risk of diffuse gastric carcinomas and lobular breast carcinoma.
- Several candidate genes are proposed to underlie the HDGC syndrome.
Conclusions:
- Understanding the genetic basis of HDGC is crucial for accurate genetic counseling.
- Presymptomatic therapeutic interventions should be offered to affected families.
- Further research into candidate genes will enhance diagnostic and therapeutic strategies.